Metabolic syndrome in type 1 diabetes mellitus. does it have any impact on the course of pregnancy?

Journal of Physiology and Pharmacology

Volumn 62, Issue 5, 2011, Pages 567-573

  Wender Ozegowska, E ^a   Zawiejska, A ^a   Michalowska Wender, G ^a   Iciek, R ^a   Wender, M ^a   Brazert, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diabetes; Metabolic syndrome; Oxidative stress; Pregnancy

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; CHRONIC DISEASE; CLINICAL FEATURE; COLORIMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THIRD TRIMESTER PREGNANCY;

ADULT; APGAR SCORE; BIOLOGICAL MARKERS; BIRTH WEIGHT; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT, NEWBORN; LIPID PEROXIDES; METABOLIC SYNDROME X; OXIDATIVE STRESS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855732868     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. McGill M, Molyneaux L, Twigg SM, Yue DK. The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J Diabetes Complications 2008; 22: 18-23.
2. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 2007; 30: 1248-1254.
3. Thorn LM, Forsblom C, Fagerudd J, et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 28: 2019-2024.
4. Thorn LM, Forsblom C, Waden J, et al. Metabolic syndrome as a risk factor for cardiovascular disease. mortality. and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2009; 32: 950-952.
5. Heptulla RA, Stewart A, Enocksson S, et al. In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study. Pediatr Res 2003; 53: 830-835.
6. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE, Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 2: 963-970.
7. Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistancerelated factors. but not glycemia. predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003; 26: 1374-1379.
8. Heptulla RA, Stewart A, Enocksson S, et al. In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study. Pediatr Res 2003; 53: 830-835.
9. Perseghin G, Price TB, Petersen KF, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357-1362.
10. Perseghin G, Lattuada G, Danna M, et al. Insulin resistance. intramyocellular lipid content. and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003; 285: E1174-E1181.
11. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-2865.
12. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Poor glycemic control and antepartum obstetric complications in women with insulin-dependent diabetes. Int J Gynaecol Obstet 1993; 43: 21-28.
13. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166: 1214-1218.
14. Pombar X, Strassner HT, Fenner PC. Pregnancy in a woman with class H diabetes mellitus and previous coronary artery bypass graft: a case report and review of the literature. Obstet Gynecol 1995; 85: 825-829.
15. Bagg W, Henley PG, MacPherson P, Cundy TF. Pregnancy in women with diabetes and ischaemic heart disease. Aust N Z J Obstet Gynaecol 1999; 39: 99-102.
16. Darias R, Herranz L, Garcia-Ingelmo MT, Pallardo LF. Pregnancy in a patient with type 1 diabetes mellitus and prior ischaemic heart disease. Eur J Endocrinol 2001; 144: 309-310.
17. Grykiel K, Zozulinska D, Kostrzewa A, Wiktorowicz K, Wierusz-Wysocka B. Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes [in Polish]. Pol Arch Med Wewn 2001; 105: 377-381.
18. Kalousova M, Fialova L, Skrha J, et al. Oxidative stress. inflammation and autoimmune reaction in type 1 and type 2 diabetes mellitus. Prague Med Rep 2004; 105: 21-28.
19. Lindschinger M, Nadlinger K, Adelwohrer N, et al. Oxidative stress: potential of distinct peroxide determination systems. Clin Chem Lab Med 2004; 42: 907-914.
20. Makimattila S, Virkamaki A, Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996; 94: 1276-1282.
21. ACOG technical bulletin. Diabetes and pregnancy. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995; 48: 331-339.
22. Grundy SM, Cleeman JI, Merz CN, et al. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004; 24: 1329-1330.
23. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239.
24. Malewski Z. Relationship between gestational age and birth weight from Poznan region. Klin Perinatol Ginekol 1995; 2: 734-741.
25. Cederberg J, Basu S, Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 2001; 44: 766-774.
26. Koubaa N, Nakbi A, Smaoui M, et al. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors. Clin Biochem 2007; 40: 1007-1014.
27. Toescu V, Nuttal SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocr 2002; 57: 609-613.
28. Wender-Ozegowska E, Kozlik J, Biczysko R, Ozegowski S. Changes of oxidative stress parameters in diabetic pregnancy. Free Radic Res 2004; 38: 795-803.
29. Orhan H, Onderoglu L, Yucel A, Sahin G. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 2003; 267: 189-195.
30. Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod Sci 2009; 16: 431-437.
31. Ruehlmann DO, Mann GE. Actions of oestrogen on vascular endothelial and smooth-muscle cells. Biochem Soc Trans 1997; 25: 40-45.
32. Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol 2010: 61: 509-521.
33. Zawiejska A, Wender-Ozegowska E, Brazert J. Microvascular complications are associated with low levels of maternal sE-selectin and sVCAM-1 in pregnancy complicated with pregestational diabetes mellitus. Diabetes Res Clin Pract 2010; 88: 164-170.
34. Campos DB, Palin MF, Bordignon V, Murphy BD. The 'beneficial' adipokines in reproduction and fertility. Int J Obes 2008; 32: 223-231.
35. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Enocr Rev 2005; 26: 439-451.
36. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue. inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
37. Krawczyk K, Szczesniak P, Kumor A, et al. Adipohormones as prognostic markers in patients with nonalcoholic steatohepatitis (NASH). J Physiol Pharmacol 2009; 60(Suppl 3): 71-75.
38. Cheng V, Kashyap SR. Weight considerations in pharmacotherapy for type 2 diabetes. J Obes 2011; 2011. pii: 984245. Epub 2010 Sep 19; doi: 10.1155/2011/984245.
39. Conway B, Miller RG, Costacou T, et al. Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med 2010; 24: 398-404.
40. Duvnjak L, Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 2009; 60(Suppl. 7): 19-24.